Elite Pharmaceuticals, Inc. Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance of 12.73 million shares as of 2024-07-01, per its 10-Q filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance · last filed 2026-02-17
- 2024-07-01: Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance 12.73M shares.
| Period end | Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance |
|---|---|
| 2024-07-01 | 12.73M shares 10-Q · filed 2026-02-17 |